Arthur King-Fan Tong, MBBS

Arthur Tong practices at Boston Eye Surgery & Laser Center Trust in Waltham, Massachusetts.

Arthur Tong's NPI, 1619942661, was assigned on February 22, 2006. Arthur Tong holds Massachusetts license 56718.

Arthur Tong's primary practice is Boston Eye Surgery & Laser Center Trust, at 52 2nd Ave, Waltham, MA 02451 in Middlesex County. The practice phone is (781) 768-5590.

Arthur Tong's primary practice is Boston Eye Surgery & Laser Center Trust in Waltham, Massachusetts. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Arthur Tong to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Arthur Tong practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Arthur Tong's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Arthur Tong is licensed in Massachusetts.

CMS data shows 2,080 Medicare services from Arthur Tong across 13 procedure codes in 2024, for 764 Medicare patients. Medicare paid $109,426 for them. Every service was in an office.

CMS counts 764 Medicare patients who saw Arthur Tong in 2024. The largest group is 75 to 84, with 325 patients. 67% of them have high cholesterol, and 64% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Arthur Tong's median patient age at 71, with 47% women.

In 2024, Arthur Tong wrote 324 Medicare Part D claims for 136 patients. 81% of them were for generic drugs. CMS names the drug for 211 of them, across 11 drugs with 11 or more claims each, at $10,466 in total drug cost. In 2023, CMS named 204 claims across 9 drugs.

Dmand AI links 1 paper to Arthur Tong in 2016. Arthur Tong's most frequent co-author is Yufei Tu, MD.

CMS Open Payments shows 2 general payments to Arthur Tong from 2 drug and device companies in 2016. Education make up the largest share, 57% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $15.